Target intelligence / Profile preview

T-cell surface glycoprotein CD3 (CD3 complex) (CD3)

Target
CD3
Molecular classification
Receptor, Signaling receptor complex adaptor
01

Overview

The T-cell surface glycoprotein CD3 (CD3 complex) is a multisubunit signaling apparatus noncovalently associated with the T-cell receptor (TCR) on T-lymphocytes, consisting of three invariant dimers: CD3εγ, CD3εδ, and CD3ζζ, in 1:1:1:1 stoichiometry with the TCRαβ heterodimer. The TCR recognizes antigenic peptides bound to MHC (pMHC) on antigen-presenting cells, while CD3 chains transduce activation signals via immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic tails, which become phosphorylated by Lck kinase to initiate downstream cascades. Each CD3 subunit features an extracellular Ig-like domain, connecting peptide, transmembrane helix, and cytoplasmic tail (ζ chain has three ITAMs). Transmembrane helices form a compact 8-helix bundle stabilized by hydrophobic and ionic interactions. Upon pMHC ligation, conformational changes expose ITAMs from the membrane inner leaflet, enabling signaling. The complex assembles as an octameric structure with TCR at the core, critical for adaptive immunity and targeted in immunotherapies.

Other names
CD3 complexCD3εγCD3εδCD3ζζTCR-CD3 complex
02

Mechanism of action

ITAM phosphorylation upon TCR-pMHC binding, leading to downstream T-cell signaling cascade; antibody binding to CD3ε induces signaling or blockade

03

Biological functions

Signal transductionAdaptive immune responseT-cell activation
04

Disease associations

CancerInfectionInflammationAutoimmune disease
05

Safety considerations

Cytokine release syndrome (with anti-CD3 therapies like OKT3)T-cell depletionimmunosuppression
06

Interacting drugs

OKT3 (muromonab-CD3)

1 more in the full profile.

07

Biomarkers

CD3 expression on T-lymphocytes (used for T-cell identification and monitoring in immunotherapy)

Beyond the preview

Go deeper on T-cell surface glycoprotein CD3 (CD3 complex) (CD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell surface glycoprotein CD3 (CD3 complex) (CD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call